AptaBio Therapeutics Inc. (KOSDAQ:293780)
4,705.00
-210.00 (-4.27%)
Jul 24, 2026, 3:30 PM KST
-48.75% (1Y)
| Market Cap | 132.18B -47.2% |
| Revenue (ttm) | 4.27B +37.5% |
| Net Income | -20.21B |
| EPS | -733.72 |
| Shares Out | 28.09M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 114,752 |
| Open | 4,795.00 |
| Previous Close | 4,915.00 |
| Day's Range | 4,625.00 - 4,995.00 |
| 52-Week Range | 3,870.00 - 10,890.00 |
| Beta | 0.82 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |